SM
ELGX

Sabby Management’s Endologix Inc ELGX Stock Holding History

Sabby Management’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-10,000
Closed -$990K – 383
2015
Q4 		$990K Hold
10,000
– – 0.05% 186
2015
Q3 		$1.23M Buy
+10,000
New +$1.36M 0.05% 211

Other funds holding ELGX

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Sabby Management's ELGX Position: Q1 2016 in Review

Sabby Management sold out of Endologix Inc (ELGX) in Q1 2016, closing a stake of 10,000 shares — an estimated $990K sold.

Sabby Management first reported a position in ELGX in Q3 2015 and held it in 2 quarters. The position peaked at $1.23M in Q3 2015. 136 funds tracked by Wall St. Rank hold ELGX as of Q1 2016.

  • Sabby Management reported no remaining Endologix Inc position as of Q1 2016 after selling out during the quarter.
  • Sabby Management sold 10,000 Endologix Inc shares in Q1 2016, an estimated $990K.
  • Sabby Management first reported a position in Endologix Inc in Q3 2015 and held it in 2 quarters.
  • Sabby Management's Endologix Inc position peaked at $1.23M in Q3 2015.
  • 136 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2016.

Based on Sabby Management's 13F filing for Q1 2016, filed 13 May 2016.